Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001529316 | SCV000730388 | likely benign | not provided | 2021-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000619056 | SCV000735432 | likely benign | Cardiovascular phenotype | 2016-07-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000864667 | SCV001005498 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2023-12-06 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001724084 | SCV002598993 | likely benign | not specified | 2022-09-05 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529316 | SCV001742554 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001724084 | SCV001955900 | benign | not specified | no assertion criteria provided | clinical testing |